
A Turning Point for Menopause Care: FDA Panel Urges Reform on Hormone Therapy Warnings
On July 17, 2025, the U.S. Food and Drug Administration (FDA) hosted a landmark expert panel to address longstanding controversies surrounding hormone replacement therapy (HRT)